« Inventing High Impact & High Value Medical Therapies: Methods & Case Studies in Clinical Innovation | Main | ZCAM »

08 May 2008


Bravo! Really wonderful framework for funding healthcare innovation. I especially like the maps of funding opportunities and milestones. We need more MBAs teaching physicians how to discover large unmet clinical opportunities - the white spaces that we collectively fail to see until the rare innovator shows us all an innovation that in hindsight seems obvious. - ML

I'm at Harvard Medical School and they still are not teaching innovation, even though many of us think we have new inventions. The new Harvard University conflict of interest rules may further prevent an innovation environment, sadly.

FasterCures alerted me to this great presentation. I agree that Harvard's Catalyst Program or CIMIT should gather innovation resources in one place so that physician-inventors can have resources and access to guidance by healthcare venture capital investors and entrepreneurs. We aren't taught any of this in medical school!

I discovered this presentation after its mention in the Wall Street Journal Health Blog today. This presentation is a fantastic counter to Oesterle's CIMIT comments, which were taken totally out of context and blown out of proportion. Dr. Chu's presentation shows how much room remains for medical innovation in medical devices, surgical tools AND biologics. Both approaches will benefit patient therapies for decades and this seminar demonstrates the best process and techniques for translating new technologies to the patient bedside and operating rooms of the future.

The Harvard community desperately needs more seminars bridging translational medicine and commercialization. The notion of Commercialization Grand Rounds could mix entrepreneurs, medical researchers and clinicians into a productive milieu for start ups. Please let me know when this gets going.

This is a really great presentation - bridging the best practices from both clinical impact and the investors' perspectives. This should be turned into a book to help physicians think about how to maximize the impact of their innovations.

You can see our schedule online at cimit.org under the forum section. But yes, we do have more of these Grand Rounds, the dates are still being worked out. I'll see what we have on capital investment for devices.

Email me for more information: mwyoung@partners.org

Is CIMIT going to have more of these Clinical Innovation Grand Rounds for Commercialization? Is there a schedule somewhere? I would also like to have a list of Boston venture capital firms investing in medical devices and biotechnology.

The comments to this entry are closed.